The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in mice.
Signal Transduct Target Ther
; 6(1): 340, 2021 09 09.
Article
in En
| MEDLINE
| ID: mdl-34504054
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Vaccines, Synthetic
/
Nanoparticles
/
COVID-19 Vaccines
/
SARS-CoV-2
/
COVID-19
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Signal Transduct Target Ther
Year:
2021
Document type:
Article
Affiliation country:
China
Country of publication:
Reino Unido